Provider: Impact Journals, LLC
TY  - JOUR
AU  - Xing, Shigui 
AU  - Li, Dongbing 
AU  - Zhao, Qi 
TI  - RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2/P53 signaling pathway
JO  - Aging
JA  - Aging (Albany NY)
VL  - 16
IS  - 17
PB  - Impact Journals, LLC
SN  - 1945-4589
UR  - https://doi.org/10.18632/aging.206096
DO  - 10.18632/aging.206096
SP  - 12392
EP  - 12413
PY  - 
ER  -